FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BETWEEN THE REGENTS OF THE UNIVERSITY OF MICHIGAN AND HEAT BIOLOGICS, INC. (UM FILE NUMBER 3680)Exclusive License Agreement • March 31st, 2017 • Heat Biologics, Inc. • Pharmaceutical preparations
This First Amendment to Exclusive License Agreement (this “First Amendment”), dated December 1, 2016, is by and between Heat Biologics, Inc. (“LICENSEE”) and the Regents of the University of Michigan (“MICHIGAN”).
FIRST AMENDMENT TO THE STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 31st, 2017 • Heat Biologics, Inc. • Pharmaceutical preparations • Delaware
This First Amendment to the Stock Purchase Agreement, dated March 29, 2017 (this “Amendment”), is made by and among Heat Biologics, Inc., a Delaware corporation (“Purchaser”), Pelican Therapeutics, Inc., a Delaware corporation (the “Company”) and Josiah Hornblower, as representative of the Stockholders (the “Stockholders’ Representative”). Capitalized terms not defined herein shall have the meanings set forth in the Stock Purchase Agreement, dated as of March 7, 2017 (as amended, modified or supplemented from time to time in accordance with its terms, the “Purchase Agreement”), by and among the Purchaser, the Company, the Stockholders party thereto and the Stockholders’ Representative.
